UBS O'Connor’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,800
Closed -$761K 285
2025
Q1
$761K Buy
+18,800
New +$761K 0.02% 192